|
Accueil > Actualité
Valneva: slashes net loss in 2024
(CercleFinance.com) - Valneva reports a net loss of E12.
2m for 2024 (including GRP proceeds) vs. a loss of E101.4m the previous year, as well as positive adjusted EBITDA of E32.9m, vs. a loss of E65.2m in 2023. The vaccines company has announced 2024 sales growth (+13% to E163.3m) and revenue targets (+10% to E169.6m), with sales of Ixiaro/Jespect up 28% to E94.1m. Valneva also boasts a solid cash position of E168.3m at end-2024, including proceeds from the sale of the Priority Review Voucher (PRV) and the private placement, as well as a 67% reduction in its operating cash consumption. Product sales expected to grow to E170m-180m in 2025, driving positive cash-flows for the overall commercial business: total revenues expected to reach E180m-E190m in 2025 Copyright (c) 2025 CercleFinance.com. All rights reserved. |
28/03/2025 17:20
BMWmise en service d'un nouvel atelier à Ratisbonne 28/03/2025 16:56 Intelle second volet de l'opération SK hynix est bouclé 28/03/2025 16:34 Equinorsigne un contrat de 330 M$ avec Island Drilling 28/03/2025 16:24 Memscaple titre surnage grâce à son carnet de commandes 28/03/2025 16:10 Hexaomchute de 58% du résultat net annuel 28/03/2025 15:55 Nanobiotixdes données favorables dans le CPNPC Tous les articles sociétés |
